11 min listen
Wildcard: 3 Diabetes Dynamos
FromIndustry Focus
ratings:
Length:
33 minutes
Released:
Feb 19, 2020
Format:
Podcast episode
Description
One in seven healthcare dollars in the United States are spent on diabetes and its related complications. That’s a huge burden for patients and for insurance companies. Thankfully, businesses are working to improve the outcomes for patients. Industry Focus Contributor Brian Feroldi joins the show to dive into three companies trying to improve diabetes treatment and monitoring: Dexcom, Tandem Diabetes, and Insulet. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter Stocks Discussed: DXCM, TNDM, PODD Click here to take our brief listener survey, and thanks for helping us out!
Released:
Feb 19, 2020
Format:
Podcast episode
Titles in the series (100)
Energy: What Wall Street Got Wrong This Week by Industry Focus